Colostomy bags are medical devices that are used by patients who have had their colon or part of it surgically removed. The bags collect the feces and waste material emptied from the surgically created stoma in the abdominal wall. Colostomy bags offer several advantages such as discreet collection and disposal of waste, convenience, odor control, and skin protection to patients undergoing colostal surgery. The rising incidence of colon cancer globally has increased the need for colostomy surgeries, thereby driving the demand for colostomy bags.
The global Colostomy Bags Market is estimated to be valued at US$ 2.90 Bn in 2024 and is expected to exhibit a CAGR of 5.6% over the forecast period 2024-2030, as highlighted in a new report published by Coherent Market Insights.
Market Opportunity:
The increasing cases of colon cancer presents a major market opportunity for colostomy bags. According to the World Cancer Research Fund, colon cancer is the third most common type of cancer globally. It is estimated that over 1.8 million new cases of colon cancer are diagnosed worldwide every year. Countries with high rates of obesity and westernized diets have witnessed rapid increase in colon cancer incidence rates in recent years. The rising burden of colon cancer will correspondingly increase the number of colostomy surgeries performed globally each year. This rising volume of colostomy procedures presents an attractive growth opportunity for manufacturers of colostomy bags to expand their business and cater to the ongoing need for these medical devices. Establishing operations in highly profitable regions and countries with high cancer rates can help companies capitalize on this opportunity.
Porter's Analysis
Threat of new entrants: The threat of new entrants is moderate as the healthcare market requires significant investment in R&D, manufacturing, and distribution to produce medical-grade products. However, the demand for colostomy bags is growing which may attract new players.
Bargaining power of buyers: The bargaining power of buyers is high as colostomy bags are medical essential products and buyers can switch between various established brands easily based on price and quality.
Bargaining power of suppliers: The bargaining power of suppliers is moderate as raw material suppliers operate in a fragmented market. However, regulatory requirements limit supplier change for medical-grade suppliers.
Threat of new substitutes: The threat of substitutes is low as there are limited product alternatives for colostomy bags which are designed for collecting fecal waste safely and discreetly.
Competitive rivalry: The competitive rivalry is high among the major global players as they focus on expanding their product portfolios and geographic presence through mergers and acquisitions.
SWOT Analysis
Strengths: Growing aging population suffering from Crohn's disease and colorectal cancer drives demand. Established brands have built trust in product quality.
Weaknesses: Storage and disposal of used bags is an inconvenience. Cost of surgery and ongoing bag supplies is a financial burden for some.
Opportunities: Emerging markets in Asia Pacific and Latin America provide scope for expansion. New adhesive formulations can improve bag adhesion and comfort.
Threats: Threat from cheaper local brands in developing nations. Strict regulations increase compliance costs.
Key Takeaways
The global colostomy bags market is expected to witness high growth between 2023-2030 driven by the rising geriatric population globally and increasing prevalence of bowel disorders. The Asia Pacific region is expected to be the fastest growing region during the forecast period owing to increasing healthcare expenditure and growing patient awareness in emerging countries like India and China. North America currently dominates the global market owing to its advanced healthcare infrastructure and presence of major players.
Key players operating in the colostomy bags market are Coloplast, ConvaTec, TG Eakin Hollister, Marlen, B. Braun Oakmed, and Welland Medical. Coloplast and ConvaTec are the leaders in terms of geographical presence and diversified product portfolio. Coloplast offers products under the SenSura, Esteem, and SpeediCath brands. ConvaTec provides products like Contiga, Dansac, and Eurotex. Companies are focusing on new product launches catering to different stoma sizes and types to strengthen their market position.